Literature DB >> 11329845

Why Bayesian analysis hasn't caught on in healthcare decision making.

R L Winkler1.   

Abstract

The objective of this paper is to discuss why Bayesian statistics is not used more in healthcare decision making and what might be done to increase the use of Bayesian methods. First, a case is made for why Bayesian analysis should be used more widely. Serious weaknesses of commonly used frequentist methods are discussed and contrasted with advantages of Bayesian methods. Next, the question of why Bayesian methods are not used more widely is addressed, considering both philosophical differences and practical issues. Contrary to what some might think, the practical issues are more important in this regard. Finally, some steps to encourage increased use of Bayesian methods in healthcare decision making are presented and discussed. These ideas are straightforward but are by no means trivial to implement, largely because it is difficult to fight tradition and make major paradigm shifts quickly. The primary needs are improved Bayesian training at the basic level (which means textbooks and other materials as well as training of those who teach at the basic level), procedures to make Bayesian analysis easier to understand and use (better software and standard methods for displaying and communicating Bayesian outputs will help here), and the education of decision makers about the advantages of Bayesian methods in important healthcare decision-making problems.

Mesh:

Year:  2001        PMID: 11329845     DOI: 10.1017/s026646230110406x

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  6 in total

1.  Bayes and health care research.

Authors:  Peter Allmark
Journal:  Med Health Care Philos       Date:  2004

Review 2.  The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis.

Authors:  Grant H Skrepnek
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.

Authors:  Rebecca A Miksad; Mithat Gönen; Thomas J Lynch; Thomas G Roberts
Journal:  J Clin Oncol       Date:  2009-03-23       Impact factor: 44.544

4.  CORR Insights®: Prediction of Postoperative Clinical Recovery of Drop Foot Attributable to Lumbar Degenerative Diseases, via a Bayesian Network.

Authors:  Raphaël Porcher
Journal:  Clin Orthop Relat Res       Date:  2017-01-03       Impact factor: 4.176

5.  Improving clinical trials using Bayesian adaptive designs: a breast cancer example.

Authors:  Wei Hong; Sue-Anne McLachlan; Melissa Moore; Robert K Mahar
Journal:  BMC Med Res Methodol       Date:  2022-05-04       Impact factor: 4.612

6.  Advantages of Bayesian monitoring methods in deciding whether and when to stop a clinical trial: an example of a neonatal cooling trial.

Authors:  Claudia Pedroza; Jon E Tyson; Abhik Das; Abbot Laptook; Edward F Bell; Seetha Shankaran
Journal:  Trials       Date:  2016-07-22       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.